Filing Details

Accession Number:
0001171843-17-005277
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-28 21:54:52
Reporting Period:
2017-08-24
Accepted Time:
2017-08-28 20:54:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
722830 Immunomedics Inc IMMU In Vitro & In Vivo Diagnostic Substances (2835) 611009366
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1029578 M David Goldenberg C/O Immunomedics, Inc
300 The American Road
Morris Plains NJ 07950
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-08-24 25,000 $10.24 0 No 4 S Indirect See Footnote
Common Stock Disposition 2017-08-28 5,000 $11.45 0 No 4 S Indirect See Footnote
Common Stock Disposition 2017-08-28 10,000 $11.56 3,415,578 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 0 Direct
Footnotes
  1. Includes a total of 635,935 shares held as joint tenants by the reporting person and his spouse, Ms. Cynthia L. Goldenberg, also known as Cynthia L. Sullivan, a director of the Company.
  2. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $10.15 to $10.31.
  3. The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
  4. Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein.
  5. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $11.55 to $11.59.